Precision Biosciences

DTILNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$193.259 M

$7.49 +0.94%

Close of 7 Aug 2026

Revenue

$34.3M

#2857 by revenue

Earnings

-$45.7M

Loss-making

Shares outstanding

27,601,554

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#97Voyager TherapeuticsVYGR$197.6M
#98Coherus OncologyCHRS$196.2M
#99Precision BiosciencesDTIL$193.3M
#100Outlook TherapeuticsOTLK$190.7M
#101Acumen PharmaceuticalsABOS$176.2M

Where these numbers come from

Share counts and financials for Precision Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.